Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Iatrogenic lupus-like syndromes].

P Demay-Wechsler

    Revue De Stomatologie Et De Chirurgie Maxillo-Faciale
    |July 1, 1976
    PubMed
    Summary

    Drug-induced lupus erythematosus (L.E.) is increasing, with various medications potentially causing or worsening this condition. Hargraves cells are the sole definitive diagnostic marker for systemic lupus erythematosus.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Familial form of incontinentia pigmenti].

    Bulletin de la Societe francaise de dermatologie et de syphiligraphie·1969
    Same author

    [Historical form of tuberculous lupus].

    Bulletin de la Societe francaise de dermatologie et de syphiligraphie·1969
    See all related articles

    Area of Science:

    • Rheumatology
    • Clinical Pharmacology

    Context:

    • Iatrogenic lupus erythematosus (L.E.) is a recognized and growing clinical concern.
    • Numerous drug classes are implicated, including hydrazine derivatives, anticonvulsants, and psychotropics.

    Purpose:

    • To review the clinical manifestations and diagnostic considerations of drug-induced lupus.
    • To highlight the diagnostic significance of Hargraves cells in systemic lupus erythematosus.

    Summary:

    • Drug-induced L.E. can mimic idiopathic L.E. without visceral involvement, aggravate existing L.E., or trigger a true L.E. with diverse symptoms.
    • While antinuclear antibodies (ANA) are indicative, Hargraves cells represent the only definitive biological marker for systemic lupus erythematosus (SLE).

    Impact:

    • Understanding drug-induced L.E. is crucial for accurate diagnosis and patient management.
    • Distinguishing drug-induced L.E. from idiopathic L.E. can prevent unnecessary treatment escalation and identify causative agents.

    Related Experiment Videos